KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardant Health (GH) Treasury Shares (2017 - 2025)

Guardant Health (GH) has disclosed Treasury Shares for 1 consecutive years, with $45.0 million as the latest value for Q3 2025.

  • Quarterly Treasury Shares fell 10.04% to $6.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $6.3 million through Dec 2025, down 10.04% year-over-year, with the annual reading at $6.3 million for FY2025, 10.04% down from the prior year.
  • Treasury Shares hit $6.3 million in Q4 2025 for Guardant Health, down from $7.6 million in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $7.9 million in Q2 2025 to a low of $333275.0 in Q1 2023.
  • Historically, Treasury Shares has averaged $3.4 million across 5 years, with a median of $3.0 million in 2022.
  • Biggest five-year swings in Treasury Shares: plummeted 85.26% in 2023 and later skyrocketed 1471.3% in 2024.
  • Year by year, Treasury Shares stood at $1.5 million in 2021, then surged by 146.1% to $3.7 million in 2022, then increased by 17.87% to $4.3 million in 2023, then soared by 61.5% to $7.0 million in 2024, then decreased by 10.04% to $6.3 million in 2025.
  • Business Quant data shows Treasury Shares for GH at $45.0 million in Q3 2025, $45.0 million in Q2 2025, and $45.0 million in Q1 2025.